SIRT3 and familial pancreatic carcinoma: Immunohistochemical analyses across 79 pancreatic cancer patients revealed a pronounced downregulation of SIRT3 in cancer tissues relative to adjacent non-cancerous tissues, with statistical significance (p < 0.001) [92].